Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
Keyword: Subarachnoid Hemorrhage
FDA Issued Complete Response Letter Citing Outstanding Items Related to Chemistry, Manufacturing, and Controls and Non-Clinical Information
FDA Does not Request Additional Clinical Data
Company In… [+10184 chars]
Read Full Story ↗
Related Content
SaaS Metrics